Cost-Effectiveness of Percutaneous Tibial Nerve Stimulation Versus Extended Release Tolterodine for Overactive Bladder
Chen HW, Bercik RS, Werner EF, Thung SF. Cost-Effectiveness of Percutaneous Tibial Nerve Stimulation Versus Extended Release Tolterodine for Overactive Bladder. Journal Of Urology 2011, 187: 178-184. PMID: 22100006, DOI: 10.1016/j.juro.2011.09.052.Peer-Reviewed Original ResearchConceptsPercutaneous tibial nerve stimulationTibial nerve stimulationQuality of lifeExtended release tolterodineIncremental cost-effectiveness ratioNerve stimulationTolterodine EROveractive bladderCost-effectiveness ratioSide effectsUrinary incontinencePercutaneous tibial nerve stimulation therapyTherapy side effectsSignificant side effectsCost-effectiveness modelMaintenance therapyImproved continencePrimary outcomeClinical circumstancesStimulation therapyMedical costsReduced qualityTherapy terminationBladderSocietal perspectiveOne-year objective and functional outcomes of a randomized clinical trial of vaginal mesh for prolapse
Sokol AI, Iglesia CB, Kudish BI, Gutman RE, Shveiky D, Bercik R, Sokol ER. One-year objective and functional outcomes of a randomized clinical trial of vaginal mesh for prolapse. American Journal Of Obstetrics And Gynecology 2011, 206: 86.e1-86.e9. PMID: 21974992, DOI: 10.1016/j.ajog.2011.08.003.Peer-Reviewed Original ResearchConceptsVaginal prolapse repairQuality of lifeReoperation rateMesh exposureProlapse repairSimilar recurrence ratesHigher reoperation rateRandomized clinical trialsProlapse stageEvaluable participantsPrimary outcomeSecondary outcomesBulge symptomsVaginal repairRecurrence rateFunctional outcomeSubjective improvementClinical trialsMesh repairVaginal meshTraditional repairMonthsOutcomesWomenProlapse